A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”.

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...

The following is a summary of “FcγR3A polymorphism influences natural killer cell activation and response to anti-PD-L1 ...

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

The SCHEQ Foundation welcomes urgent support to expand its mission of increasing STEMM diversity and improving cancer care outcomes for ...

Researchers at AIIMS, Delhi have developed a simple blood test using droplet digital PCR (ddPCR) to track the effectiveness of cervical cancer treatment. Published in Scientific Reports, the study ...

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response.  They are secreted by ...

Using a novel method that gives a readout of which proteins are in specific locations within cells, UT Southwestern Medical ...

Van Andel Institute scientists and collaborators have developed a new method for identifying and classifying pancreatic ...

The fatigue and lack of motivation that many cancer patients experience near the end of life have been seen as the ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors -- a smart fighter that destroys cancer cells for days without tiring. Biomedical engineers have made this ...